Related Experiment Video
Updated: Aug 15, 2026

The Adventures of Fundi Intervention Based on the Cognitive and Emotional Processing in Attention Deficit Hyperactive Disorder Patients
Published on: June 12, 2020
A double-blind drug trial of treatment in young children with waking problems
Insights
Trimeprazine tartrate offered some sleep improvement for children with severe waking issues, but the effects were moderate and not permanent. Follow-up revealed most children continued to experience sleep problems.
Area of Science:
- Pediatrics
- Sleep Medicine
- Pharmacology
Background:
- Severe waking problems significantly impact children's well-being and development.
- Effective and safe pharmacological interventions for pediatric sleep disturbances are needed.
Purpose of the Study:
- To evaluate the efficacy of trimeprazine tartrate in managing severe waking problems in children.
- To assess the short-term and long-term effects of trimeprazine tartrate on pediatric sleep patterns.
Main Methods:
- A double-blind, placebo-controlled trial was conducted with 22 children experiencing severe waking problems.
- Parental verbal reports and daily sleep diaries were used to collect data on sleep quality and duration.
- A 6-month follow-up was performed on a subset of participants to assess lasting effects.
Main Results:
- Parental reports indicated a significant improvement in sleep with trimeprazine tartrate compared to baseline and placebo.
- Parental sleep diaries revealed only moderate clinical improvement, with frequent wakeful periods persisting.
- No permanent positive effect on sleep patterns was observed post-treatment.
Conclusions:
- Trimeprazine tartrate may offer a short-term, moderate benefit for severe pediatric waking problems.
- The drug's effects on sleep are not sustained, and long-term sleep issues remain prevalent.
- Further research into sustained and non-pharmacological interventions for pediatric sleep disturbances is warranted.
Abstract:
A double-blind trial using trimeprazine tartrate was carried out in 22 children with severe waking problems. On parental verbal reports sleep was significantly improved on the drug compared with the original baseline and the placebo, but diaries kept by the parents showed that this improvement was clinically only moderate, with many wakeful nights still occurring. Taking the drug produced no permanent effect on sleep patterns and a follow-up of 14 children 6 months later showed persisting sleep problems in the majority.
More Related Videos
10:02Event Related Potentials (ERPs) and other EEG Based Methods for Extracting Biomarkers of Brain Dysfunction: Examples from Pediatric Attention Deficit/Hyperactivity Disorder (ADHD)
Published on: March 12, 2020
07:20Repeated Transcranial Magnetic Stimulation Combined with Action Observation Training in Children with Spastic Cerebral Palsy
Published on: August 9, 2024